pharma.markets

pharma.markets

  • HOME
  • Imprint

europe

CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022

08/12/2022 MaP 0

On December 6, 2022, CABIO Biotech (Wuhan) Co., Ltd (CABIO), a leading Chinese biotechnology company, took part in the three-day Food Ingredients Europe 2022 (Fi […]

Medison Pharma Announces Multi-Regional Partnership Agreement with argenx

06/06/2022 MaP 0

…..to Commercialize Efgartigimod Across Europe and Israel Medison Pharma (“Medison”), a global pharma company focused on providing access to highly innovative therapies to patients in […]

Spain Covid-19 vaccination 3rd best in Europe 8.3.2021

08/03/2021 MaP 0

Europe’s Beating Cancer Plan: A new EU approach to prevention, treatment and care

03/02/2021 MaP 0

Today, on the eve of the World Cancer Day, the European Commission is presenting Europe’s Beating Cancer Plan – a main priority in the area […]

photo NIAID

Vaccine roll-out to begin, thanks to the EU Strategy for COVID-19 vaccines

15/12/2020 MaP 0

Sandra Gallina, Director General of the European Commission’s Directorate General for Health and Food Safety, talks about the imminent roll-out of COVID-19 vaccines. The EU […]

European Medicines Agency EMA has Launched Third Rolling Review of a COVID-19 Vaccine Candidate for Europe

04/12/2020 MaP 0

The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has started the third rolling review process, the evaluation of […]

EU Commission Pharmaceutical Strategy for Europe -Affordable, accessible and safe medicines for all

01/12/2020 MaP 0

The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, […]

Building a European Health Union: Stronger crisis preparedness and response for Europe

01/12/2020 MaP 0

Today, the European Commission is taking the first steps towards building the European Health Union announced by President von der Leyen in her State of […]

EU Commission takes first step towards adoption of a Pharmaceutical Strategy for Europe

04/06/2020 MaP 0

As a first step towards the adoption of a Pharmaceutical Strategy for Europe the Commission yesterday published a roadmap, inviting interested citizens and stakeholders to […]

The EU budget for recovery increases funds for a stronger Europe in the world

02/06/2020 MaP 0

As part of the revised long-term EU budget 2021-2027 package, the European Commission has proposed a budget of €118.2 billion for external action, with an […]

Roche’s OCREVUS (ocrelizumab) shorter 2-hour infusion time approved in Europe

28/05/2020 MaP 0

• Reduces infusion time to 2 hours from the conventional 3.5 hours for patients with relapsing or primary progressive multiple sclerosis • EMA approval based […]

Reinforcing Europe’s resilience: halting biodiversity loss and building a healthy and sustainable food system

20/05/2020 MaP 0

Today, the European Commission adopted a comprehensive new Biodiversity Strategy to bring nature back into our lives and a Farm to Fork Strategy for a […]

copyright European Commission 2020

Coronavirus: President von der Leyen sets out the main features of the Recovery Plan for Europe

14/05/2020 MaP 0

Yesterday, President von der Leyen gave a speech at the European Parliament plenary debate on the new Multiannual Financial Framework, own resources and the Recovery […]

Investment Plan for Europe supports €50 million financing agreement with Pluristem to develop coronavirus therapies

30/04/2020 MaP 0

Today, the European Investment Bank signed a €50 million financing agreement with Israeli regenerative medicine company Pluristem – through its German subsidiary Pluristem GmbH – […]

Coronavirus: President von der Leyen outlines EU budget as Marshall Plan for Europe’s recovery

16/04/2020 MaP 0

Today, President Ursula von der Leyen gave a speech at the European Parliament plenary session on the EU’s coordinated action to fight the coronavirus pandemic […]

Posts navigation

1 2 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Alzheimer
  • Animal health
  • Asthma
  • Bioscience
  • Cancer
  • Conferences
  • Cosmetics
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Food
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • Innovation
  • Mental Health
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • Spain
  • Sports
  • Therapy
  • Trade Fair
  • UN
  • Vaccines
  • Valencia Comunidad
  • WHO

Reports

  • Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®
  • Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer
  • BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer
  • Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant

Archive

  • February 2023 (3)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®

    04/02/2023 0
  • Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer

    04/02/2023 0
  • BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility

    02/02/2023 0
  • CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

    27/01/2023 0
  • Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant

    26/01/2023 0
Archives
  • February 2023 (3)
  • January 2023 (6)
  • December 2022 (16)
  • November 2022 (11)
  • October 2022 (14)
  • September 2022 (1)
  • August 2022 (4)
  • July 2022 (3)
  • June 2022 (8)
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid bayer biontech cancer commission companies coronavirus covid-19 covid19 economy elpais.com emergency eu europe european fda food global guarantee health hygiene investment links medical merck novartis pandemic pfizer production recommendations region response roche safety scheme sector spain state statistics support test vaccine who

Copyright © 2023 | WordPress Theme by MH Themes

Cookie Consent with Real Cookie Banner